Approval · Notice of Compliance 17664 · 2016
BUTRANS: Notice of Compliance 17664
Issued January 12, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17664
- Date
- January 12, 2016
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUTRANS | 02450771 | Marketed |
Medicinal ingredients
- BUPRENORPHINE 15 MCG per HR